Shin Nippon Biomedical Laboratories, Ltd. (2395.T)
JPY 1537.0
(-1.22%)
JPY 1537.0
(-1.22%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 42.14 Billion JPY | 36.46% |
| 2022 | 30.88 Billion JPY | 57.65% |
| 2021 | 19.58 Billion JPY | -7.31% |
| 2020 | 21.13 Billion JPY | -6.57% |
| 2019 | 22.62 Billion JPY | -12.5% |
| 2018 | 25.85 Billion JPY | -17.65% |
| 2017 | 31.39 Billion JPY | -7.07% |
| 2016 | 33.77 Billion JPY | 6.34% |
| 2015 | 31.76 Billion JPY | 2.77% |
| 2014 | 30.9 Billion JPY | 5.16% |
| 2013 | 29.39 Billion JPY | -2.72% |
| 2012 | 30.21 Billion JPY | 1.23% |
| 2011 | 29.84 Billion JPY | -3.04% |
| 2010 | 30.78 Billion JPY | -4.1% |
| 2009 | 32.09 Billion JPY | 4.1% |
| 2008 | 30.83 Billion JPY | 22.63% |
| 2007 | 25.14 Billion JPY | 10.34% |
| 2006 | 22.78 Billion JPY | 27.35% |
| 2005 | 17.89 Billion JPY | 0.67% |
| 2004 | 17.77 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 48.3 Billion JPY | 14.63% |
| 2023 Q4 | 42.14 Billion JPY | 2.49% |
| 2023 Q2 | 36.83 Billion JPY | 2.67% |
| 2023 Q1 | 35.87 Billion JPY | 16.17% |
| 2023 Q3 | 41.11 Billion JPY | 11.63% |
| 2023 FY | 42.14 Billion JPY | 36.46% |
| 2022 Q3 | 30.34 Billion JPY | -4.79% |
| 2022 Q2 | 31.87 Billion JPY | 32.49% |
| 2022 Q1 | 24.05 Billion JPY | 22.8% |
| 2022 FY | 30.88 Billion JPY | 57.65% |
| 2022 Q4 | 30.88 Billion JPY | 1.78% |
| 2021 Q4 | 19.58 Billion JPY | 4.99% |
| 2021 Q2 | 18.72 Billion JPY | -3.98% |
| 2021 Q1 | 19.5 Billion JPY | -7.72% |
| 2021 FY | 19.58 Billion JPY | -7.31% |
| 2021 Q3 | 18.65 Billion JPY | -0.36% |
| 2020 Q3 | 21 Billion JPY | 1.45% |
| 2020 Q1 | 23.39 Billion JPY | 3.42% |
| 2020 Q2 | 20.7 Billion JPY | -11.49% |
| 2020 FY | 21.13 Billion JPY | -6.57% |
| 2020 Q4 | 21.13 Billion JPY | 0.61% |
| 2019 Q3 | 21.82 Billion JPY | -5.68% |
| 2019 FY | 22.62 Billion JPY | -12.5% |
| 2019 Q1 | 23.33 Billion JPY | -9.74% |
| 2019 Q2 | 23.13 Billion JPY | -0.84% |
| 2019 Q4 | 22.62 Billion JPY | 3.64% |
| 2018 FY | 25.85 Billion JPY | -17.65% |
| 2018 Q3 | 26.2 Billion JPY | -11.12% |
| 2018 Q2 | 29.48 Billion JPY | -2.47% |
| 2018 Q1 | 30.23 Billion JPY | -3.69% |
| 2018 Q4 | 25.85 Billion JPY | -1.36% |
| 2017 Q4 | 31.39 Billion JPY | -4.11% |
| 2017 Q3 | 32.73 Billion JPY | 11.78% |
| 2017 Q2 | 29.28 Billion JPY | 0.34% |
| 2017 Q1 | 29.18 Billion JPY | -13.59% |
| 2017 FY | 31.39 Billion JPY | -7.07% |
| 2016 Q1 | 31.58 Billion JPY | -0.55% |
| 2016 Q2 | 35.04 Billion JPY | 10.94% |
| 2016 FY | 33.77 Billion JPY | 6.34% |
| 2016 Q4 | 33.77 Billion JPY | -0.41% |
| 2016 Q3 | 33.91 Billion JPY | -3.22% |
| 2015 Q1 | 29.88 Billion JPY | -3.3% |
| 2015 Q3 | 32.44 Billion JPY | -1.98% |
| 2015 Q2 | 33.1 Billion JPY | 10.75% |
| 2015 FY | 31.76 Billion JPY | 2.77% |
| 2015 Q4 | 31.76 Billion JPY | -2.09% |
| 2014 Q3 | 29.66 Billion JPY | 1.32% |
| 2014 FY | 30.9 Billion JPY | 5.16% |
| 2014 Q4 | 30.9 Billion JPY | 4.2% |
| 2014 Q1 | 26.08 Billion JPY | -11.26% |
| 2014 Q2 | 29.27 Billion JPY | 12.24% |
| 2013 Q3 | 30.59 Billion JPY | -1.01% |
| 2013 Q2 | 30.9 Billion JPY | 9.72% |
| 2013 Q1 | 28.16 Billion JPY | -6.76% |
| 2013 FY | 29.39 Billion JPY | -2.72% |
| 2013 Q4 | 29.39 Billion JPY | -3.94% |
| 2012 Q1 | 28.31 Billion JPY | -5.11% |
| 2012 Q4 | 30.21 Billion JPY | -3.26% |
| 2012 Q3 | 31.22 Billion JPY | -4.42% |
| 2012 Q2 | 32.67 Billion JPY | 15.38% |
| 2012 FY | 30.21 Billion JPY | 1.23% |
| 2011 Q4 | 29.84 Billion JPY | -4.05% |
| 2011 Q3 | 31.1 Billion JPY | -1.79% |
| 2011 Q2 | 31.67 Billion JPY | 6.13% |
| 2011 Q1 | 29.84 Billion JPY | -3.05% |
| 2011 FY | 29.84 Billion JPY | -3.04% |
| 2010 FY | 30.78 Billion JPY | -4.1% |
| 2010 Q1 | 30.55 Billion JPY | -4.82% |
| 2010 Q2 | 33.27 Billion JPY | 8.9% |
| 2010 Q3 | 32.94 Billion JPY | -0.99% |
| 2010 Q4 | 30.78 Billion JPY | -6.55% |
| 2009 Q4 | 32.09 Billion JPY | -1.91% |
| 2009 FY | 32.09 Billion JPY | 4.1% |
| 2009 Q3 | 32.72 Billion JPY | 13.57% |
| 2009 Q2 | 28.81 Billion JPY | 0.0% |
| 2008 FY | 30.83 Billion JPY | 22.63% |
| 2008 Q4 | 30.83 Billion JPY | 5.84% |
| 2008 Q3 | 29.13 Billion JPY | 0.0% |
| 2007 FY | 25.14 Billion JPY | 10.34% |
| 2006 FY | 22.78 Billion JPY | 27.35% |
| 2005 FY | 17.89 Billion JPY | 0.67% |
| 2004 FY | 17.77 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| DNA Chip Research Inc. | 250.12 Million JPY | -16748.462% |
| Cosmo Bio Company,Limited | 1.84 Billion JPY | -2181.63% |
| H.U. Group Holdings, Inc. | 152.84 Billion JPY | 72.429% |
| FALCO HOLDINGS Co., Ltd. | 10.39 Billion JPY | -305.365% |
| BML, Inc. | 40.85 Billion JPY | -3.162% |
| Human Metabolome Technologies, Inc. | 656.68 Million JPY | -6317.33% |
| Precision System Science Co., Ltd. | 2.25 Billion JPY | -1769.902% |